Eiger BioPharmaceuticals, Inc. (EIGRQ)
OTCMKTS · Delayed Price · Currency is USD
8.50
0.00 (0.00%)
Inactive · Last trade price on Oct 1, 2024
Eiger BioPharmaceuticals Employees
Eiger BioPharmaceuticals had 25 employees as of December 31, 2023. The number of employees decreased by 31 or -55.36% compared to the previous year.
Employees
25
Change (1Y)
-31
Growth (1Y)
-55.36%
Revenue / Employee
$630,920
Profits / Employee
-$2,998,520
Market Cap
12.59M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 25 | -31 | -55.36% |
Dec 31, 2022 | 56 | 13 | 30.23% |
Dec 31, 2021 | 43 | 15 | 53.57% |
Dec 31, 2020 | 28 | 4 | 16.67% |
Dec 31, 2019 | 24 | 6 | 33.33% |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Eiger BioPharmaceuticals News
- 1 year ago - Amylyx to buy bankrupt Eiger's experimental drug to treat low blood sugar - Reuters